Clinical Trial Update: Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating the combination of flavopiridol, cytarabine, and mitoxantrone in adults with acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Flavopiridol (alvocidib)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED